Human Papillomavirus
View Featured Related Documents View all Featured
Quadrivalent Human Papillomavirus Vaccine Initiation, Coverage, and Compliance Among U.S. Active Component Service Women, 2006-2011 -  Consistent with ACIP recommendations, the DoD has made the HPV4 vaccine available to all eligible service members aged 17–26 years. Despite vaccine availability, utilization of the HPV4 vaccine by active component U.S. service women has been reported to be low.
AAP recommends immunization against human papillomavirus (HPV) for all 11- through 12-year-old children as part of the adolescent immunization program.